On April 26, 2013, Ergoresearch Inc., a subsidiary of the publicly-listed Ergoresearch Ltd., acquired all of the outstanding securities of Victhom Human Bionics Inc. for a total consideration of $4.1 million pursuant to a court-approved plan of arrangement, whereby Ergoresearch Inc. amalgamated with Victhom to continue as a wholly-owned subsidiary of Ergoresearch Ltd. operating under the name “Victhom Laboratory Inc.”. Fasken Martineau acted for Ergoresearch with a team that included Michel Boislard, Caitlin Rose, Anabel Quessy (corporate/securities) and Jean-Philippe Mikus (intellectual property).